Krsnaa Diagnost. Q2 FY27 Results (NSE: KRSNAA)
Signal: Margin pressure
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹270.97 Cr | +31.6% | +15.0% |
| EBIT | ₹42.07 Cr | -28.9% | |
| Net profit | ₹24.59 Cr | +2.7% | |
| EPS | ₹7.64 | +3.5% | |
| EBIT margin | 26.25% |
P&L walk
Consolidated revenue increased to 2709.69 million, +31.6% YoY and +15.0% QoQ, while gross margin expanded 278bps to 79.40%; higher fees to hospitals and others of 507.06 million versus 169.98 million YoY drove EBITDA margin down 247bps to 26.25%, limiting PAT growth to 2.7% at 245.87 million.
Research and educational content only. Not investment advice.